RetCAD™ is MDR class IIa CE 0344-certified software, powered by artificial intelligence. It instantly analyses fundus images for the presence of vision-threatening eye diseases. After taking the fundus image of the patient’s eyes, it takes less than 1 minute to get a detailed report that will show the condition of the analysed retina. Even very early symptoms typical for diseases such as Age-related Macular Degeneration (AMD) and Diabetic Retinopathy (DR), can be detected and assessed with a severity score, at least as accurate as when conducted by a human expert. Outcomes of the screening are then simultaneously translated into a simply visualised patient report in a chosen language. The RetCAD™ patient report not only shows the screened eyes’ condition but also provides a clear fact-based recommendation if further examination or treatment is required.